Cancer Neutron Capture Therapy pp 137-141 | Cite as
Synthesis, Tissue Uptake, and Toxicity of a Nickel Tetracarboranylphenylporphyrin
Abstract
Porphyrins have been used for boron neutron capture therapy [BNCT] and photodynamic therapy [PDT] of experimental rodent tumors. PDT requires much less porphyrin than BNCT, typically 5 μg as compared to > 200 μg per gram body weight [gbw]. Toxicity is a major consideration in the use of boronated drugs for BNCT. At 265 μg/gbw, a boronated porphyrin, VCDP [1] (Figure 1) delivered 40 μg B/g to tumor tissue 4 days after the last of 12 intraperitoneal [ip] injections.1 There was transient hematologic and hepatic toxicity. If the VCDP dose rate was kept low (22 μg/gbw per ip injection; 12 injections over 4 days), lethality was under 10%. A tetraphenylporphyrin [2] containing four meta-nido-carborane cages was synthesized2 and when tested in mice found to be much more toxic than VCDP.
Keywords
Boron Concentration Boron Neutron Capture Therapy Diacetic Acid Boron Analysis Carborane CagePreview
Unable to display preview. Download preview PDF.
References
- 1.M. Miura, P.L. Micca, J.C. Heinrichs, D. Gabel, R.G. Fairchild, and D.N. Slatkin, Biodistribution and toxicity of 2,4-divinyl-nido-o-carboranyldeuteroporphyrin IX in mice, Biochem. Pharm. 43: 467–476, 1992.PubMedCrossRefGoogle Scholar
- 2.M. Miura, D. Gabel, G. Oenbrink, R. Fairchild, Synthesis of boronated porphyrins for boron neutron capture therapy, Tetrahedron Lett. 31: 2247–2250, 1990.CrossRefGoogle Scholar
- 3.A.R. Morgan, G.M. Garbo, M. Kreimer-Birnbaum, R.W. Keck, K Chardhuri, and S.H. Selman, Morphological study of the combined effect of purpurin derivatives and light on transplantable rat bladder tumors, Cancer Res. 47: 496–498, 1987.PubMedGoogle Scholar
- 4.J.S. Lindsey, I.C. Schreiman, H. Hsu, P.C. Kearney, A.M. Marguerettaz, Rothemund and Adler-Longo reactions revisited: Synthesis of tetraphenylporphyrins under equilibrium conditions, J. Org. Chem. 52: 827–836, 1987.CrossRefGoogle Scholar
- 5.G.P. Chiusoli, M. Costa, S. Reverberi, Synthesis of pyrrole-3,4-diacetic acid and its derivatives, Syn. 1989: 262–265.Google Scholar
- 6.K. Woodburn, C.K. Chang, S. Lee, B. Henderson, and D. Kessel, Biodistribution and PDT efficacy of a ketochlorin photosensitizer as a function of the delivery vehicle, Photochem. Photobiol. 60: 154–159, 1994.PubMedCrossRefGoogle Scholar
- 7.M. Miura, S.A. Majumder, J.D. Hobbs, M.W. Renner, L.R. Furenlid and J.A. Shelnutt, Synthesis and spectroscopic characterization of octaacetic acid-tetraphenylporphyrins, Inorg. Chem., 33, 6078–6085, 1994.CrossRefGoogle Scholar
- 8.A.M. Richter, E. Waterfield, A.K. Jain, A.J. Canaan, B.A. Allison and J.G. Levy, Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring a (BPD), to tumor tissue in a mouse tumor model, Photochem. Photobiol. 57: 1000–1006, 1993.PubMedCrossRefGoogle Scholar
- 9.M.M. Zuk, B.D. Rihter, M.E. Kenney, M.A.J. Rodgers and M. Kreimer-Birnbaum, Pharmacokinetic and tissue distribution studies of the photosensitizer bis(di-isobutyl octadecylsiloxy)silicon 2,3-naphthalocyanine (isoBOSINC) in normal and tumor-bearing rats, Photochem. Photobiol., 59: 66–72, 1994.PubMedCrossRefGoogle Scholar